Heron Therapeutics to Present at the 21st Annual Virtual Needham Healthcare Conference

Rhea-AI Summary

Heron Therapeutics, Inc. (Nasdaq: HRTX) will participate in a fireside chat at the 21^st Annual Virtual Needham Healthcare Conference on April 11, 2022, at 8:00 am PT. The event aims to discuss the company's innovative approaches to addressing unmet patient needs in acute care and oncology through best-in-class treatments. A live webcast will be available on the company's website in the Investor Resources section. For more information about Heron and its products, please visit www.herontx.com.

SAN DIEGO, April 5, 2022 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that company management will participate in a fireside chat at the 21^st Annual Virtual Needham Healthcare Conference on Monday, April 11, 2022 at 8:00 am PT/11:00 am ET.

A live webcast of the fireside chat will be available on the Company's website at www.herontx.com in the Investor Resources section.

About Heron Therapeutics, Inc.

Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard-of-care for acute care and oncology patients. For more information, visit www.herontx.com.

Forward-looking Statements

This news release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Heron cautions readers that forward-looking statements are based on management's expectations and assumptions as of the date of this news release and are subject to certain risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include, but are not limited to, risks and uncertainties identified in the Company's filings with the Securities and Exchange Commission. Forward-looking statements reflect our analysis only on their stated date, and Heron takes no obligation to update or revise these statements except as may be required by law.

Investor Relations and Media Contact:
David Szekeres
Executive Vice President, Chief Operating Officer
Heron Therapeutics, Inc.
dszekeres@herontx.com
858-251-4447

View original content:https://www.prnewswire.com/news-releases/heron-therapeutics-to-present-at-the-21st-annual-virtual-needham-healthcare-conference-301518270.html

SOURCE Heron Therapeutics, Inc.

FAQ

When will Heron Therapeutics present at the Needham Healthcare Conference?

Heron Therapeutics will present at the 21st Annual Virtual Needham Healthcare Conference on April 11, 2022, at 8:00 am PT.

Where can I watch the Heron Therapeutics conference presentation?

The fireside chat can be viewed live on the Heron Therapeutics website in the Investor Resources section.

What is the focus of Heron Therapeutics?

Heron Therapeutics focuses on developing best-in-class treatments to address unmet needs in acute care and oncology.

What is Heron Therapeutics' stock symbol?

The stock symbol for Heron Therapeutics is HRTX.

Who can I contact for investor relations at Heron Therapeutics?

David Szekeres is the contact for investor relations; he can be reached at 858-251-4447 or via email at dszekeres@herontx.com.